Trial Profile
Outcomes among Patients with Type 2 Diabetes (T2D) Receiving Basal Insulin with Mealtime Insulin or Exenatide BID: A Retrospective Study Using Real-World Electronic Medical Record Data
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Sep 2019
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 30 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.